14 Best 52-Week High Stocks To Buy According to Analysts

Page 13 of 13

1. NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)

52 Week Range: $15.19 – $27.29

Current Share Price: $23.67

Stock Upside Potential: 78.08%

Number of Hedge Fund Holders: 29

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) is a late-stage biopharmaceutical company that develops therapies to enhance patient care in populations with metabolic diseases. It is developing anacetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor. The stock has been flying high and remains one of the best 52-week high stocks to buy, according to analysts, owing to a string of positive news on the development of its pipeline of drugs.

In 2024, NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) announced that three Phase 3 trials of its lead products had produced favorable topline results. TANDEM achieved 49% LDL-C reduction with fixed-dose combination; BROOKLYN showed 36% LDL-C reduction; and BROADWAY showed 33% LDL-C reduction and 21% MACE reduction. NewAmsterdam Pharma exited 2024 with $835 million in the balance sheet, sufficient to accelerate the development of the three programs.

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) is gearing up for significant commercial demand through its manufacturing scale-up and inventory build-out strategy. A European commercialization partnership with Menarini further validates its efforts and enhances income potential. The company is optimistic about Obicetrapib’s long-term prospects, having secured patent protection until 2043. Currently, it is focusing on commercial readiness by establishing manufacturing capacity, which strengthens its intellectual property portfolio and long-term revenue potential.

While we acknowledge the growth potential of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than NAMS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 13 of 13